Skip to main content
. 2022 Jun;28(6):1128–1136. doi: 10.3201/eid2806.212262

Table 2. Univariable and multivariable analysis of 30-day all-cause and Clostridioides difficile–attributable mortality, Canada, 2015–2019*.

Characteristics Univariable analysis
Multivariable analysis
Odds ratio (95% CI) p value Adjusted odds ratio (95% CI) p value
All-cause mortality
Sex
M Referent Referent
F 1.15 (0.91–1.45) 0.2484 1.26 (0.93–1.70) NS
Age group, y
<65 Referent Referent
>65 2.66 (2.00–3.53) <0.0001 3.63 (2.45–5.39) <0.0001
Severe CDI† 2.53 (1.90–3.36) <0.0001 2.66 (1.90–3.73) <0.0001
CDI case type
Community-associated Referent Referent
Healthcare-associated 1.65 (1.21–2.24) 0.0014 1.83 (1.23–2.72) 0.0028
RT027 vs. non-RT027 1.48 (1.04–2.10) 0.0289 1.10 (0.74–1.63) NS
RT106 vs. non-RT106
1.09 (0.73–1.63)
0.6804

NA

CDI-attributable mortality
Sex
M Referent Referent
F 1.22 (0.79–1.87) 0.3776 1.33 (0.81–1.19) NS
Age group, y
<65 Referent Referent
>65 3.28 (1.84–5.85) <0.0001 3.44 (1.73–6.82) 0.0004
Severe CDI† 2.40 (1.45–4.0) 0.0006 2.25 (1.28–3.94) 0.0050
CDI case type
Community-associated Referent Referent
Healthcare-associated 1.29 (0.76–2.22) 0.3476 1.25 (0.67–2.35) NS
RT027 vs. non-RT027 3.17 (1.89–5.29) <0.0001 2.85 (1.64–5.00) 0.0002
RT106 vs. non-RT106 0.95 (0.45–2.00) 0.8830 NA

*Bold text indicates statistical significance. CDI, Clostridioides difficile infection; NA, not applicable; NS, not significant; RT, ribotype. †Severe CDI defined as albumin level <30 g/L, leukocyte count >15 × 109 cells/L, or both.